First human tests begin for experimental stroke pill
NCT ID NCT07371455
Summary
This is the first human study testing a new oral medication called LWP779, which is being developed to treat ischemic stroke. Researchers are giving the drug to 76 healthy volunteers to check if it's safe, how the body processes it, and what side effects might occur. The study will test different single and multiple doses to gather initial safety data before testing in stroke patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CMAX Clinical Research Pty Ltd
RECRUITINGAdelaide, Australia
Conditions
Explore the condition pages connected to this study.